The Individualized Treatment of Opioid Use Disorder.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 31134856.
- Also identified by DOI 10.18553/jmcp.2019.25.6.634 and PMC identifier 10398294.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
No outside funding supported the writing of this commentary. Boyett is Chief Medical Officer and founder of the medical division of Pathway Healthcare, which provides treatment for opioid and other drug addictions.
Medical subject headings
- Opioid-Related Disorders